SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (6241)4/29/2002 4:21:15 PM
From: sammaster  Respond to of 52153
 
amgn seems to be very overvalued by its p/sales ratio compared to its market cap and prospects for growth...
smaller caps like sepr mlnm scio seem to have same or lower p/s ratio but have much higher potential growth rates...

if amgn becomes to be valued as a "big pharma" then stock price is really going to drop